Literature DB >> 3731074

Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo.

R Bjerkvig, O D Laerum, O Mella.   

Abstract

Two malignant rat neurogenic cell lines have been confronted with reaggregation cultures of fetal rat brain in a stationary culture system. In this organ culture system several morphological aspects of the developing brain are imitated. The malignant cell lines showed invasive and progressive growth into the brain tissue, ending with a completely destroyed aggregate within 10 days of coculture. One cell line (BT5C) showed solid invasion with groups of cells replacing different layers of the brain tissue. A considerable degree of normal cell lysis was seen, both at the edge of invasion and at distant parts of the aggregate. This cell line seemed to activate macrophages in the aggregates. In addition, conditioned medium from these cultures caused degeneration of the brain aggregates. The other cell line (BT4Cn) showed invasion by single cells where the replacement and destruction of the tissue was not accompanied by distant lysis. Both cell lines showed the same pattern of invasion in vitro as was seen in the brains of isogeneic animals in vivo, showing that the individual tumor characteristics were also reflected during invasive growth in organ culture.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731074

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Dynamics of C6 astrocytoma invasion into three-dimensional collagen gels.

Authors:  R D Maestro; R Shivers; W McDonald; A D Maestro
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  A cerebral glioma model for experimental therapy and in vivo invasion studies in syngeneic BD IX rats.

Authors:  O Mella; R Bjerkvig; B C Schem; O Dahl; O D Laerum
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

Review 3.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

4.  Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression.

Authors:  S Khoshyomn; S Lew; J DeMattia; E B Singer; P L Penar
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.

Authors:  Peter Vajkoczy; Pjotr Knyazev; Andrea Kunkel; Hans-Holger Capelle; Sandra Behrndt; Hendrik von Tengg-Kobligk; Fabian Kiessling; Uta Eichelsbacher; Marco Essig; Tracy-Ann Read; Ralf Erber; Axel Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

Review 6.  Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.

Authors:  Shreyas S Rao; John J Lannutti; Mariano S Viapiano; Atom Sarkar; Jessica O Winter
Journal:  Tissue Eng Part B Rev       Date:  2013-10-30       Impact factor: 6.389

7.  Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion.

Authors:  A P Amar; S J DeArmond; D R Spencer; P F Coopersmith; D M Ramos; M L Rosenblum
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture.

Authors:  M Lund-Johansen; K Forsberg; R Bjerkvig; O D Laerum
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 9.  The biology and mathematical modelling of glioma invasion: a review.

Authors:  J C L Alfonso; K Talkenberger; M Seifert; B Klink; A Hawkins-Daarud; K R Swanson; H Hatzikirou; A Deutsch
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

10.  Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.

Authors:  W Günther; E Pawlak; R Damasceno; H Arnold; A J Terzis
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.